Bioventix (BVXP)

 

BVXP Share PerformanceMore

52 week high1,600.0 17/10/16
52 week low899.5 25/07/16
52 week change 400.0 (34.78%)
4 week volume66,900 28/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Five shares for the watchlist

Companies analyst Richard Beddard trawls through corporate results to pick great stocks for his portfolio. Here he profiles...

Holding(s) in Company

For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Bioventix (Sedol B4QVDF0 ) 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or...

Holding(s) in Company

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Bioventix PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal of qualifying financial instruments which m...

Bioventix resolutions passed at AGM

Bioventix has confirmed that all resolutions put to shareholders at the annual general meeting yesterday were passed. At 8:5...

Result of AGM

Bioventix plc (?Bioventix? or the ?Company?) Result of AGM Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting held earlier today, all resolutions put to shareholders were duly passed. For further information please contact: Bioventix plc Peter Harrison Chief Executive Officer Tel: 01252 728 001 finnCap Ltd Geoff Nash/Simon Hicks Stephen N...

Director/PDMR Shareholding

Bioventix plc (?Bioventix? or the ?Company?) Director/PDMR Shareholding Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for application in clinical diagnostics, was notified on 18 November 2016 of the following transactions in its ordinary shares of 5 pence each (?Ordinary Shar...

Notice of AGM

Bioventix plc (?Bioventix? or the ?Company?) Notice of AGM and Posting of Annual Report Bioventix plc (AIM: BVXP) announces that its Annual General Meeting will be held at The Winchester Suite, Farnham Castle, Farnham, Surrey, GU9 0AG at 2.00 p.m. on Wednesday 7 December 2016. Copies of the 2016 Annual Report and the Notice of the Annual General M...

Broker Forecast - finnCap issues a broker note on Bioventix Plc

finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and raised its price target to 1450p ...

Fundamental DataMore

P/E ratio22.405
EPS69.18
Dividend yield2.742 %

Latest discussion posts More

  • Director Sales

    Not sure I like today's RNS
    7-Dec-2016
    Hardboy
  • Re: Finals

    "but why would anyone sell today" A good question Buy on the rumour and sell on the news. I made a note in late April to buy on the 200x moving average, achieved early ...
    20-Oct-2016
    seadoc
  • Re: Finals

    I know we have had a good rise of late, so profit taking is always likely, but why would anyone sell today>? Might as well hang on for the dividend & special dividend - only ...
    17-Oct-2016
    Hardboy

Users' HoldingsMore

Users who hold Bioventix also hold..
SOMERO ENTER DI32%
LLOYDS GRP.28%
GLAXOSMITHKLINE26%
ZYTRONIC24%
OPTIBIOTIX H.22%

Codes & Symbols

ISINGB00B4QVDF07
SymbolsBVXP, LSE:BVXP, BVXP.L, BVXP:LN, LON:BVXP, XLON:BVXP